Combined mitoxantrone and anti-TGFβ treatment with PD-1 blockade enhances antitumor immunity by remodelling the tumor immune landscape in neuroblastoma
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Combined mitoxantrone and anti-TGFβ treatment with PD-1 blockade enhances antitumor immunity by remodelling the tumor immune landscape in neuroblastoma
Authors
Keywords
-
Journal
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
Volume 41, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-11-17
DOI
10.1186/s13046-022-02525-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Immunotherapy of Neuroblastoma: Facts and Hopes
- (2022) John Anderson et al. CLINICAL CANCER RESEARCH
- Immune checkpoint molecules in neuroblastoma: A clinical perspective
- (2022) Anup S. Pathania et al. SEMINARS IN CANCER BIOLOGY
- Dendritic Cells: Behind the Scenes of T-Cell Infiltration into the Tumor Microenvironment
- (2021) Valeria Lucarini et al. Cancers
- Key chemokines direct migration of immune cells in solid tumors
- (2021) Karan Kohli et al. CANCER GENE THERAPY
- Chemotherapeutic and targeted agents can modulate the tumor microenvironment and increase the efficacy of immune checkpoint blockades
- (2021) Jun-Yan Li et al. Molecular Cancer
- Single-cell transcriptomics reveals the effect of PD-L1/TGF-β blockade on the tumor microenvironment
- (2021) Yoong Wearn Lim et al. BMC BIOLOGY
- Simultaneous targeting of TGF-β/PD-L1 synergizes with radiotherapy by reprogramming the tumor microenvironment to overcome immune evasion
- (2021) Yan Lan et al. CANCER CELL
- Cell surface Nucleolin represents a novel cellular target for neuroblastoma therapy
- (2021) Chiara Brignole et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Restoring the Immunity in the Tumor Microenvironment: Insights into Immunogenic Cell Death in Onco-Therapies
- (2021) Ángela-Patricia Hernández et al. Cancers
- ACCELERATE and European Medicines Agency Paediatric Strategy Forum for medicinal product development of checkpoint inhibitors for use in combination therapy in paediatric patients
- (2020) Andrew D.J. Pearson et al. EUROPEAN JOURNAL OF CANCER
- Influence of the Tumor Microenvironment on NK Cell Function in Solid Tumors
- (2020) Ombretta Melaiu et al. Frontiers in Immunology
- Dual targeting of TGF-β and PD-L1 via a bifunctional anti-PD-L1/TGF-βRII agent: status of preclinical and clinical advances
- (2020) Hanne Lind et al. Journal for ImmunoTherapy of Cancer
- Selective inhibition of TGFβ1 activation overcomes primary resistance to checkpoint blockade therapy by altering tumor immune landscape
- (2020) Constance J. Martin et al. Science Translational Medicine
- News on immune checkpoint inhibitors as immunotherapy strategies in adult and pediatric solid tumors
- (2020) Ombretta Melaiu et al. SEMINARS IN CANCER BIOLOGY
- Venetoclax increases intra-tumoral effector T cells and anti-tumor efficacy in combination with immune checkpoint blockade
- (2020) Frederick J Kohlhapp et al. Cancer Discovery
- Cellular and gene signatures of tumor-infiltrating dendritic cells and natural-killer cells predict prognosis of neuroblastoma
- (2020) Ombretta Melaiu et al. Nature Communications
- The immune landscape of neuroblastoma: Challenges and opportunities for novel therapeutic strategies in pediatric oncology
- (2020) Judith Wienke et al. EUROPEAN JOURNAL OF CANCER
- Enhancing anti-tumor response by combining immune checkpoint inhibitors with chemotherapy in solid tumors
- (2019) K M Heinhuis et al. ANNALS OF ONCOLOGY
- Developmental origins and emerging therapeutic opportunities for childhood cancer
- (2019) Mariella Filbin et al. NATURE MEDICINE
- Transforming Growth Factor-β Signaling in Immunity and Cancer
- (2019) Eduard Batlle et al. IMMUNITY
- Immune induction strategies in metastatic triple-negative breast cancer to enhance the sensitivity to PD-1 blockade: the TONIC trial
- (2019) Leonie Voorwerk et al. NATURE MEDICINE
- IL-33 Promotes CD11b/CD18-Mediated Adhesion of Eosinophils to Cancer Cells and Synapse-Polarized Degranulation Leading to Tumor Cell Killing
- (2019) Sara Andreone et al. Cancers
- Enhanced Tumor Retention Effect by Click Chemistry for Improved Cancer Immunochemotherapy
- (2018) Ling Mei et al. ACS Applied Materials & Interfaces
- NK Cells Stimulate Recruitment of cDC1 into the Tumor Microenvironment Promoting Cancer Immune Control
- (2018) Jan P. Böttcher et al. CELL
- Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018
- (2018) Lorenzo Galluzzi et al. CELL DEATH AND DIFFERENTIATION
- A natural killer–dendritic cell axis defines checkpoint therapy–responsive tumor microenvironments
- (2018) Kevin C. Barry et al. NATURE MEDICINE
- Cancer immunotherapy using checkpoint blockade
- (2018) Antoni Ribas et al. SCIENCE
- Enhanced preclinical antitumor activity of M7824, a bifunctional fusion protein simultaneously targeting PD-L1 and TGF-β
- (2018) Yan Lan et al. Science Translational Medicine
- Synergistic and low adverse effect cancer immunotherapy by immunogenic chemotherapy and locally expressed PD-L1 trap
- (2018) Wantong Song et al. Nature Communications
- M7824, a novel bifunctional anti-PD-L1/TGFβ Trap fusion protein, promotes anti-tumor efficacy as monotherapy and in combination with vaccine
- (2018) Karin M. Knudson et al. OncoImmunology
- TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells
- (2018) Sanjeev Mariathasan et al. NATURE
- Combining Type I Interferons and 5-Aza-2′-Deoxycitidine to Improve Anti-Tumor Response against Melanoma
- (2017) Valeria Lucarini et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- CAR T Cells Administered in Combination with Lymphodepletion and PD-1 Inhibition to Patients with Neuroblastoma
- (2017) Andras Heczey et al. MOLECULAR THERAPY
- PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity
- (2017) Sydney R. Gordon et al. NATURE
- COX2/mPGES1/PGE2pathway regulates PD-L1 expression in tumor-associated macrophages and myeloid-derived suppressor cells
- (2017) Victor Prima et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Tumour and host cell PD-L1 is required to mediate suppression of anti-tumour immunity in mice
- (2017) Janet Lau et al. Nature Communications
- Ex Vivo Profiling of PD-1 Blockade Using Organotypic Tumor Spheroids
- (2017) Russell W. Jenkins et al. Cancer Discovery
- Organs on chip approach: a tool to evaluate cancer -immune cells interactions
- (2017) Elena Biselli et al. Scientific Reports
- Temporally Distinct PD-L1 Expression by Tumor and Host Cells Contributes to Immune Escape
- (2017) Takuro Noguchi et al. Cancer Immunology Research
- A novel bifunctional anti-PD-L1/TGF-β Trap fusion protein (M7824) efficiently reverts mesenchymalization of human lung cancer cells
- (2017) Justin M. David et al. OncoImmunology
- 3D Microfluidic model for evaluating immunotherapy efficacy by tracking dendritic cell behaviour toward tumor cells
- (2017) Stefania Parlato et al. Scientific Reports
- Targeting the tumor microenvironment: removing obstruction to anticancer immune responses and immunotherapy
- (2016) J. M. Pitt et al. ANNALS OF ONCOLOGY
- Critical Role for CD103 + /CD141 + Dendritic Cells Bearing CCR7 for Tumor Antigen Trafficking and Priming of T Cell Immunity in Melanoma
- (2016) Edward W. Roberts et al. CANCER CELL
- Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic Melanoma
- (2016) Willy Hugo et al. CELL
- TGFβR1 Blockade with Galunisertib (LY2157299) Enhances Anti-Neuroblastoma Activity of the Anti-GD2 Antibody Dinutuximab (ch14.18) with Natural Killer Cells
- (2016) Hung C. Tran et al. CLINICAL CANCER RESEARCH
- Immune Checkpoint Blockade: A Common Denominator Approach to Cancer Therapy
- (2015) Suzanne L. Topalian et al. CANCER CELL
- PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma
- (2015) Stephen M. Ansell et al. NEW ENGLAND JOURNAL OF MEDICINE
- The future of immune checkpoint therapy
- (2015) P. Sharma et al. SCIENCE
- PD-1 expression on dendritic cells suppresses CD8+ T cell function and antitumor immunity
- (2015) Tong Seng Lim et al. OncoImmunology
- Tumor-infiltrating T lymphocytes improve clinical outcome of therapy-resistant neuroblastoma
- (2015) Marco Mina et al. OncoImmunology
- Dissecting the Tumor Myeloid Compartment Reveals Rare Activating Antigen-Presenting Cells Critical for T Cell Immunity
- (2014) Miranda L. Broz et al. CANCER CELL
- Tumor-associated neutrophils stimulate T cell responses in early-stage human lung cancer
- (2014) Evgeniy B. Eruslanov et al. JOURNAL OF CLINICAL INVESTIGATION
- Reversible and adaptive resistance to BRAF(V600E) inhibition in melanoma
- (2014) Chong Sun et al. NATURE
- Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients
- (2014) Roy S. Herbst et al. NATURE
- PD-1 blockade induces responses by inhibiting adaptive immune resistance
- (2014) Paul C. Tumeh et al. NATURE
- Natural Killer Cells and Neuroblastoma: Tumor Recognition, Escape Mechanisms, and Possible Novel Immunotherapeutic Approaches
- (2014) Cristina Bottino et al. Frontiers in Immunology
- IL-18-Primed Helper NK Cells Collaborate with Dendritic Cells to Promote Recruitment of Effector CD8+ T Cells to the Tumor Microenvironment
- (2013) J. L. Wong et al. CANCER RESEARCH
- Engineering anti-GD2 monoclonal antibodies for cancer immunotherapy
- (2013) Mahiuddin Ahmed et al. FEBS LETTERS
- Peripheral Prepositioning and Local CXCL9 Chemokine-Mediated Guidance Orchestrate Rapid Memory CD8+ T Cell Responses in the Lymph Node
- (2013) Wolfgang Kastenmüller et al. IMMUNITY
- Anticancer Chemotherapy-Induced Intratumoral Recruitment and Differentiation of Antigen-Presenting Cells
- (2013) Yuting Ma et al. IMMUNITY
- Protumor and antitumor functions of neutrophil granulocytes
- (2012) Sven Brandau et al. Seminars in Immunopathology
- On the dual roles and polarized phenotypes of neutrophils in tumor development and progression
- (2011) H. Piccard et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- T cell exhaustion
- (2011) E John Wherry NATURE IMMUNOLOGY
- Preclinical Models for Neuroblastoma: Establishing a Baseline for Treatment
- (2011) Tal Teitz et al. PLoS One
- miRNA Expression Profiling of the Murine TH-MYCN Neuroblastoma Model Reveals Similarities with Human Tumors and Identifies Novel Candidate MiRNAs
- (2011) Marta Terrile et al. PLoS One
- Recent Advances in Neuroblastoma
- (2010) John M. Maris NEW ENGLAND JOURNAL OF MEDICINE
- Polarization of Tumor-Associated Neutrophil Phenotype by TGF-β: “N1” versus “N2” TAN
- (2009) Zvi G. Fridlender et al. CANCER CELL
- Vα24-invariant NKT cells mediate antitumor activity via killing of tumor-associated macrophages
- (2009) Liping Song et al. JOURNAL OF CLINICAL INVESTIGATION
- TGFβ in Cancer
- (2008) Joan Massagué CELL
- The International Neuroblastoma Risk Group (INRG) Classification System: An INRG Task Force Report
- (2008) Susan L. Cohn et al. JOURNAL OF CLINICAL ONCOLOGY
- Histological profile of tumours from MYCN transgenic mice
- (2008) H C Moore et al. JOURNAL OF CLINICAL PATHOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now